ISPOR - Potential Cost Savings Of Having Access To Antipsychotic Plasma Levels At The Point Of Care For Patients With Schizophrenia

Full Text

Potential Cost Savings Of Having Access To Antipsychotic Plasma Levels At The Point Of Care For Patients With Schizophrenia

Abstract

Authors

MA Pobre R Riley Z Predmore M Horvitz-Lennon S Mattke

Back to Volume 19, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now